{"id":"https://openalex.org/W24978359","doi":null,"title":"[Antiplatelet effects of glycoproteins IIb-IIIa antagonist monafram].","display_name":"[Antiplatelet effects of glycoproteins IIb-IIIa antagonist monafram].","alternate_titles":[],"publication_year":2004,"publication_date":"2004-05-01","ids":{"openalex":"https://openalex.org/W24978359","mag":"24978359","pmid":"https://pubmed.ncbi.nlm.nih.gov/15341084"},"language":"ru","primary_location":{"id":"pmid:15341084","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15341084","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W24978359"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112150540","display_name":"A V Mazurov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A V Mazurov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041322878","display_name":"\u041f\u0435\u0432\u0437\u043d\u0435\u0440 \u0414\u043c\u0438\u0442\u0440\u0438\u0439 \u0412\u043e\u043b\u044c\u0444\u043e\u0432\u0438\u0447","orcid":"https://orcid.org/0000-0002-5290-0065","observed_orcids":["https://orcid.org/0000-0002-5290-0065"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D V Pevzner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082042667","display_name":"Tatjana N. Vlasik","orcid":"https://orcid.org/0000-0001-7058-1080","observed_orcids":["https://orcid.org/0000-0001-7058-1080"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T N Vlasik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5108249042","display_name":"Mikhail Ya. Ruda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Ia Ruda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7789,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.74908887,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"90","issue":"5","first_page":"586","last_page":"599"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.7056000232696533,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.7056000232696533,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.28690001368522644,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glycoprotein-iib-iiia-antagonists","display_name":"glycoprotein IIb/IIIa antagonists","score":0.8989999890327454},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.8809999823570251},{"id":"https://openalex.org/keywords/platelet-inhibition","display_name":"platelet aggregation inhibition","score":0.8379999995231628},{"id":"https://openalex.org/keywords/adp-induced-platelet-aggregation","display_name":"ADP-induced aggregation","score":0.7919999957084656},{"id":"https://openalex.org/keywords/thrombin-induced-aggregation","display_name":"thrombin-induced aggregation","score":0.8610000014305115},{"id":"https://openalex.org/keywords/platelet-granule-secretion","display_name":"platelet granule secretion","score":0.921999990940094},{"id":"https://openalex.org/keywords/coronary-angioplasty","display_name":"coronary angioplasty","score":0.7770000100135803},{"id":"https://openalex.org/keywords/ischemic-heart-disease","display_name":"ischemic heart disease","score":0.9020000100135803},{"id":"https://openalex.org/keywords/abciximab","display_name":"abciximab","score":0.5619999766349792},{"id":"https://openalex.org/keywords/bleeding-complications","display_name":"bleeding complications","score":0.5870000123977661},{"id":"https://openalex.org/keywords/myocardial-infarction-prevention","display_name":"myocardial infarction prevention","score":0.753000020980835},{"id":"https://openalex.org/keywords/recurrent-angina","display_name":"recurrent angina","score":0.8379999995231628}],"concepts":[{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.714073657989502},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6855118870735168},{"id":"https://openalex.org/C43376680","wikidata":"https://www.wikidata.org/wiki/Q6580786","display_name":"Bolus (digestion)","level":2,"score":0.5420417189598083},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.49913692474365234},{"id":"https://openalex.org/C2780326628","wikidata":"https://www.wikidata.org/wiki/Q539795","display_name":"Angioplasty","level":2,"score":0.4911632239818573},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4907461404800415},{"id":"https://openalex.org/C2777785093","wikidata":"https://www.wikidata.org/wiki/Q2032041","display_name":"Unstable angina","level":3,"score":0.4885922074317932},{"id":"https://openalex.org/C26828662","wikidata":"https://www.wikidata.org/wiki/Q7202248","display_name":"Platelet membrane glycoprotein","level":3,"score":0.4810624122619629},{"id":"https://openalex.org/C2777871224","wikidata":"https://www.wikidata.org/wiki/Q307088","display_name":"Abciximab","level":4,"score":0.47650542855262756},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4467332363128662},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.4411674439907074},{"id":"https://openalex.org/C3018697912","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Platelet activation","level":3,"score":0.4284381866455078},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36117023229599},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.34091320633888245},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13933014869689941},{"id":"https://openalex.org/C45393284","wikidata":"https://www.wikidata.org/wiki/Q191012","display_name":"Conventional PCI","level":3,"score":0.10517227649688721}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006967","descriptor_name":"Hypersensitivity","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D007140","descriptor_name":"Immunoglobulin Fab Fragments","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007140","descriptor_name":"Immunoglobulin Fab Fragments","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007140","descriptor_name":"Immunoglobulin Fab Fragments","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010974","descriptor_name":"Platelet Aggregation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015550","descriptor_name":"Cell Degranulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019039","descriptor_name":"Platelet Glycoprotein GPIIb-IIIa Complex","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019039","descriptor_name":"Platelet Glycoprotein GPIIb-IIIa Complex","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:15341084","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15341084","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2419113447","https://openalex.org/W2070901420","https://openalex.org/W2326940115","https://openalex.org/W2293220210","https://openalex.org/W2326328478","https://openalex.org/W2068916210","https://openalex.org/W2152303123","https://openalex.org/W3035063514","https://openalex.org/W2436939515","https://openalex.org/W2246880911"],"abstract_inverted_index":{"First":[0],"Russian":[1],"glycoprotein":[2],"(GP)":[3],"IIb-IIIa":[4,14,48,169],"antagonist,":[5],"preparation":[6,159],"Monafram,":[7],"is":[8],"the":[9,209],"F(ab')2":[10],"fragment":[11],"of":[12,119,139,167,188,199,211],"anti-GP":[13],"monoclonal":[15],"antibody":[16],"FRaMon.":[17],"In":[18],"in":[19,61,68,186],"vitro":[20],"experiments":[21],"it":[22],"was":[23,144,150],"shown":[24],"that":[25],"Monafram":[26,56,82,120,142,149,207],"blocked":[27],"platelet":[28,38,54,91],"aggregation":[29,92,140],"induced":[30],"by":[31,93,146],"ADP":[32],"and":[33,40,67,99,105,121,165,173,181,194,215,219],"thrombin;":[34],"reduced":[35],"secretion":[36],"from":[37,152,222],"granules;":[39],"due":[41],"to":[42,53,224],"simultaneous":[43],"interaction":[44],"with":[45,70],"two":[46],"GP":[47,168],"molecules":[49],"almost":[50],"irreversibly":[51],"bound":[52],"surface.":[55],"clinical":[57],"trials":[58],"were":[59,114,184],"performed":[60],"healthy":[62],"volunteers":[63],"(n":[64,79],"=":[65,80],"10)":[66],"patients":[69],"ischemic":[71],"heart":[72],"disease":[73],"undergoing":[74],"high":[75],"risk":[76],"coronary":[77,205],"angioplasty":[78,206],"153).":[81],"intravenous":[83],"bolus":[84,127],"administration":[85,143],"at":[86,101,124,132,170],"0.25":[87,125],"mg/kg":[88,126],"decreased":[89,208],"ADP-induced":[90],"more":[94,161],"than":[95,162],"90,":[96,163],"80,":[97],"60":[98],"30%":[100],"1,":[102,171],"12,":[103],"24":[104],"72":[106,174],"h":[107,130,175],"after":[108,141,176,204],"injection,":[109,177],"respectively.":[110,178],"No":[111],"significant":[112],"differences":[113],"detected":[115,185],"between":[116],"antiaggregatory":[117],"effects":[118],"ReoPro":[122],"introduced":[123],"+":[128],"12":[129,155],"infusion":[131],"0.125":[133],"microg/kg":[134],"per":[135],"min.":[136],"Durable":[137],"inhibition":[138],"mediated":[145],"platelet-bound":[147,158],"preparation--free":[148],"cleared":[151],"plasma":[153],"within":[154],"h,":[156],"while":[157],"occupied":[160],"70-80":[164],"40-50%":[166],"12-24":[172],"Major":[179],"bleedings":[180],"allergic":[182],"reactions":[183],"none":[187],"patients,":[189],"deep":[190],"thrombocytopenia--in":[191],"one":[192,202],"patient":[193],"antibodies":[195],"against":[196],"Monafram--in":[197],"5%":[198],"patients.":[200],"Within":[201],"month":[203],"number":[210],"end":[212],"points":[213],"(fatal":[214],"nonfatal":[216],"myocardial":[217],"infarction":[218],"angina":[220],"recurrence)":[221],"11.4":[223],"3.3%.":[225]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W24978359","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
